Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008

Fatimah S Dawood1, Anthony Fiore, Laurie Kamimoto

  • 1Epidemic Intelligence Service, Centers forDisease Control and Prevention , Atlanta, GA, USA. fdawood@cdc.gov

Insights

Hospitalized children with influenza-associated pneumonia face severe illness, including higher risks of intensive care, respiratory failure, and death. Young children (6 months to 4 years) and those with asthma are most vulnerable to this complication.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Public Health Surveillance

Background:

  • Influenza is a common cause of hospitalization in children.
  • Influenza-associated pneumonia is a significant complication in this population.
  • Understanding risk factors for pneumonia in hospitalized children with influenza is crucial.

Purpose of the Study:

  • To describe hospitalized children with influenza-associated pneumonia.
  • To identify risk indicators associated with influenza-associated pneumonia in children.
  • To inform prevention and treatment strategies for at-risk children.

Main Methods:

  • Population-based surveillance of children (<18 years) hospitalized with laboratory-confirmed influenza and chest radiograph.
  • Defined influenza-associated pneumonia as new pneumonia on chest radiograph during hospitalization.
  • Compared children with and without pneumonia using univariate and multivariate analysis.

Main Results:

  • 36% of hospitalized children with influenza had pneumonia (1072/2992).
  • Pneumonia cases had higher rates of ICU admission (21% vs. 11%), respiratory failure (11% vs. 3%), and death (0.9% vs. 0.3%).
  • Risk factors included age 6-23 months, age 2-4 years, and asthma.

Conclusions:

  • Influenza-associated pneumonia leads to a more severe clinical course in hospitalized children.
  • Children aged 6 months to 4 years and those with asthma are at increased risk.
  • Identifying at-risk children can guide targeted prevention and treatment efforts.
Abstract

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: